Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas
Hiroshi Fuji, Tetsuo Nishimura(Subaru (Japan)), Yuji Ishida(Shizuoka Cancer Center), Uwe Schneider(University of Zurich), Hirofumi Asakura(Kagawa University), Masahiro Konno(Shizuoka Cancer Center), Hirofumi Ogawa(Shizuoka Cancer Center), Shigeyuki Murayama, Haruo Yamashita(Shizuoka Cancer Center), Yuki Kase(Yokogawa Electric (Japan)), Hideyuki Harada(Shizuoka Cancer Center), Tsuyoshi Onoe(Shizuoka Cancer Center)
Cited by 28
Related Papers
Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion Beams
|Radiation Research|2006|353
Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model
|Physics in Medicine and Biology|2010|318
AAPM task group 224: Comprehensive proton therapy machine quality assurance
|Medical Physics|2019|228
Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation
|Physics in Medicine and Biology|2007|176
Contributions of Direct and Indirect Actions in Cell Killing by High-LET Radiations
|Radiation Research|2009|156